| Baseline history of major PAD | Hazard ratios (major PAD vs. not) | ||||||
---|---|---|---|---|---|---|---|---|
No (n = 10,624) | Yes (n = 516) | Model 1 | Model 2 | |||||
HR | 95Â % CI | p | HR | 95Â % CI | p | |||
All-cause mortality, n (%) | 2101 (19.8) | 164 (31.8) | 1.57 | 1.33–1.84 | <0.0001 | 1.35 | 1.15–1.60 | 0.0004 |
Major macrovascular events, n (%) | 2025 (19.1) | 141 (27.3) | 1.59 | 1.34–1.88 | <0.0001 | 1.47 | 1.23–1.75 | <0.0001 |
Cardiovascular death, n (%) | 904 (8.5) | 84 (16.3) | 1.99 | 1.59–2.49 | <0.0001 | 1.75 | 1.39–2.21 | <0.0001 |
Myocardial infarction, n (%) | 665 (6.3) | 57 (11.0) | 1.76 | 1.34–2.31 | <0.0001 | 1.58 | 1.19–2.09 | 0.001 |
Stroke, n (%) | 924 (8.7) | 44 (8.5) | 1.24 | 0.92–1.68 | 0.16 | 1.19 | 0.87–1.62 | 0.28 |
Major clinical microvascular events, n (%) | 763 (7.2) | 44 (8.5) | 1.43 | 1.05–1.94 | 0.02 | 1.31 | 0.96–1.78 | 0.09 |
Retinal photocoagulation or blindness, n (%) | 632 (5.9) | 37 (7.2) | 1.48 | 1.06–2.07 | 0.02 | 1.39 | 0.99–1.95 | 0.05 |
End-stage renal disease or renal death, n (%) | 160 (1.5) | 8 (1.6) | 1.15 | 0.56–2.34 | 0.71 | 0.96 | 0.46–1.97 | 0.90 |